HU9901911D0 - Diaza-spiro[3,5]nanone derivatives - Google Patents
Diaza-spiro[3,5]nanone derivativesInfo
- Publication number
- HU9901911D0 HU9901911D0 HU9901911A HUP9901911A HU9901911D0 HU 9901911 D0 HU9901911 D0 HU 9901911D0 HU 9901911 A HU9901911 A HU 9901911A HU P9901911 A HUP9901911 A HU P9901911A HU 9901911 D0 HU9901911 D0 HU 9901911D0
- Authority
- HU
- Hungary
- Prior art keywords
- nanone
- diaza
- spiro
- derivatives
- nanone derivatives
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/10—Spiro-condensed systems
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/08—Antiepileptics; Anticonvulsants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/18—Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/22—Anxiolytics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/24—Antidepressants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/28—Drugs for disorders of the nervous system for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/04—Anorexiants; Antiobesity agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
EP98110804 | 1998-06-12 |
Publications (3)
Publication Number | Publication Date |
---|---|
HU9901911D0 true HU9901911D0 (en) | 1999-08-30 |
HUP9901911A1 HUP9901911A1 (hu) | 2000-05-28 |
HU220894B1 HU220894B1 (en) | 2002-06-29 |
Family
ID=8232114
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HU9901911A HU220894B1 (en) | 1998-06-12 | 1999-06-09 | Orphanin fq (ofq) receptor agonist and/or antagonist diaza-spiro[3,5]nonane derivatives, preparation and use thereof |
Country Status (28)
Country | Link |
---|---|
US (1) | US6113527A (hu) |
EP (1) | EP0970957B1 (hu) |
JP (1) | JP3286268B2 (hu) |
KR (1) | KR100344732B1 (hu) |
CN (1) | CN1107066C (hu) |
AR (1) | AR019859A1 (hu) |
AT (1) | ATE204279T1 (hu) |
AU (1) | AU743983B2 (hu) |
BR (1) | BR9902651A (hu) |
CA (1) | CA2274202A1 (hu) |
DE (1) | DE69900220T2 (hu) |
DK (1) | DK0970957T3 (hu) |
ES (1) | ES2162503T3 (hu) |
HR (1) | HRP990188A2 (hu) |
HU (1) | HU220894B1 (hu) |
ID (1) | ID23304A (hu) |
IL (1) | IL130377A0 (hu) |
MA (1) | MA26644A1 (hu) |
NO (1) | NO312590B1 (hu) |
NZ (1) | NZ336189A (hu) |
PE (1) | PE20000548A1 (hu) |
PL (1) | PL333695A1 (hu) |
PT (1) | PT970957E (hu) |
SG (1) | SG79259A1 (hu) |
SI (1) | SI0970957T1 (hu) |
TR (1) | TR199901381A3 (hu) |
YU (1) | YU26499A (hu) |
ZA (1) | ZA993852B (hu) |
Families Citing this family (15)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20030040479A1 (en) * | 2001-07-02 | 2003-02-27 | Omeros Corporation | Rotational intrathecal analgesia method and device |
WO2003004034A1 (en) * | 2001-07-02 | 2003-01-16 | Omeros Corporation | Method for inducing analgesia comprising administration alternatively of an opioid receptor agonist and an opioid receptor like receptor 1 agonist for and an implantable infusion pump |
DK1491212T3 (da) | 2002-03-29 | 2012-10-29 | Mitsubishi Tanabe Pharma Corp | Middel til behandling af søvnforstyrrelser |
JP2005289816A (ja) | 2002-05-14 | 2005-10-20 | Banyu Pharmaceut Co Ltd | ベンズイミダゾール誘導体 |
NZ537214A (en) | 2002-07-05 | 2007-08-31 | Targacept Inc | N-Aryl diazaspiracyclic compounds capable of affecting nicotinic cholinergic receptors and methods of preparation and use thereof |
NZ538307A (en) * | 2002-09-09 | 2008-04-30 | Janssen Pharmaceutica Nv | Hydroxy alkyl substituted 1,3,8-triazaspiro[4.5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
GB0323204D0 (en) * | 2003-10-03 | 2003-11-05 | Novartis Ag | Organic compounds |
WO2005060947A2 (en) * | 2003-12-19 | 2005-07-07 | Sri International | Agonist and antagonist ligands of the nociceptin receptor |
US20060178390A1 (en) * | 2004-08-02 | 2006-08-10 | Alfonzo Jordan | 1,3,8-Triazaspiro[4,5]decan-4-one derivatives useful for the treatment of ORL-1 receptor mediated disorders |
JP2008510711A (ja) * | 2004-08-20 | 2008-04-10 | ターガセプト,インコーポレイテッド | 嗜癖治療におけるn−アリールジアザスピラ環状化合物の使用 |
US20080247964A1 (en) * | 2006-05-08 | 2008-10-09 | Yuelian Xu | Substituted azaspiro derivatives |
AU2007325355A1 (en) * | 2006-11-28 | 2008-06-05 | Janssen Pharmaceutica N.V. | Salts of 3-(3-amino-2-(R)-hydroxy-propyl)-1-(4-fluoro-phenyl)-8-(8-methyl-naphthalen-1-ylmethyl) -1,3,8-triaza-spiro[4.5]decan-4-one |
US8741916B2 (en) * | 2007-04-09 | 2014-06-03 | Janssen Pharmaceutica Nv | 1,3,8-trisubstituted-1,3,8-triaza-spiro[4.5]decan-4-one derivatives as ligands of the ORL-1 receptor |
KR101704226B1 (ko) | 2015-06-30 | 2017-02-07 | 현대자동차주식회사 | 자동차의 쿼터글라스 어셈블리 |
WO2023122662A1 (en) * | 2021-12-22 | 2023-06-29 | The Regents Of The University Of California | Covalently binding inhibitors of g12s, g12d and/or g12e mutants of k-ras gtpase |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US5756743A (en) * | 1996-04-10 | 1998-05-26 | Hoechst Marion Roussel Inc. | Spiro cyclopent b!indole-piperidines! |
-
1999
- 1999-06-07 DE DE69900220T patent/DE69900220T2/de not_active Expired - Lifetime
- 1999-06-07 DK DK99110943T patent/DK0970957T3/da active
- 1999-06-07 AT AT99110943T patent/ATE204279T1/de not_active IP Right Cessation
- 1999-06-07 SI SI9930008T patent/SI0970957T1/xx unknown
- 1999-06-07 ES ES99110943T patent/ES2162503T3/es not_active Expired - Lifetime
- 1999-06-07 EP EP99110943A patent/EP0970957B1/en not_active Expired - Lifetime
- 1999-06-07 PT PT99110943T patent/PT970957E/pt unknown
- 1999-06-08 PE PE1999000487A patent/PE20000548A1/es not_active Application Discontinuation
- 1999-06-08 ZA ZA9903852A patent/ZA993852B/xx unknown
- 1999-06-08 ID IDP990543D patent/ID23304A/id unknown
- 1999-06-09 HU HU9901911A patent/HU220894B1/hu not_active IP Right Cessation
- 1999-06-09 IL IL13037799A patent/IL130377A0/xx unknown
- 1999-06-09 CA CA002274202A patent/CA2274202A1/en not_active Abandoned
- 1999-06-09 SG SG9903066A patent/SG79259A1/en unknown
- 1999-06-09 NZ NZ336189A patent/NZ336189A/xx unknown
- 1999-06-10 KR KR1019990021485A patent/KR100344732B1/ko not_active IP Right Cessation
- 1999-06-10 AU AU34987/99A patent/AU743983B2/en not_active Ceased
- 1999-06-10 YU YU26499A patent/YU26499A/sh unknown
- 1999-06-10 MA MA25616A patent/MA26644A1/fr unknown
- 1999-06-10 AR ARP990102763A patent/AR019859A1/es active IP Right Grant
- 1999-06-10 JP JP16357099A patent/JP3286268B2/ja not_active Expired - Fee Related
- 1999-06-11 BR BR9902651-1A patent/BR9902651A/pt not_active Application Discontinuation
- 1999-06-11 NO NO19992873A patent/NO312590B1/no unknown
- 1999-06-11 US US09/330,851 patent/US6113527A/en not_active Expired - Fee Related
- 1999-06-11 HR HR98110804.6A patent/HRP990188A2/hr not_active Application Discontinuation
- 1999-06-11 CN CN99108373A patent/CN1107066C/zh not_active Expired - Fee Related
- 1999-06-11 PL PL99333695A patent/PL333695A1/xx unknown
- 1999-06-11 TR TR1999/01381A patent/TR199901381A3/tr unknown
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
ZA98570B (en) | 8-substituted-1,3,8-triaza-spiro[4,5]decan-4-on derivatives | |
PL346155A1 (en) | 1h-imidazopyridine derivatives | |
PL345540A1 (en) | Thiobenzimidazole derivatives | |
HK1022310A1 (en) | Benzosulfone derivatives | |
SI0921125T1 (en) | 1,3,8-Triazaspiro(4,5)decan-4-on derivatives | |
GB9910384D0 (en) | Alpha-ketoamide derivatives | |
SG71173A1 (en) | 1,3,8,-triaza-spiro[4,5]decan-4-on derivatives | |
IL134220A0 (en) | 6,9-bridged erythromycin derivatives | |
IL126624A0 (en) | 3-descladinose-2, 3-anhydroerythromycin derivatives | |
IL134996A0 (en) | 6,11-bridged erythromycin derivatives | |
HU9901911D0 (en) | Diaza-spiro[3,5]nanone derivatives | |
ZA982969B (en) | 1,2,3,4-tetrahydro-benzofuro[3,2-c]pyridine derivatives. | |
IL137518A0 (en) | Derivatives of 1,2,4-oxadiazolone | |
EG23802A (en) | 2-Phenylpyran-4-one derivatives | |
HUP0003692A3 (en) | Pyrimido[4,5-b]indolyl-alkanecarboxamide derivatives | |
GB9827729D0 (en) | Thieno-indole derivatives | |
EP1061912A4 (en) | PHENANTHROFURANDERIVATE | |
SG70589A1 (en) | 1, 25-Dihydroxy-16, 22, 23-trisdehydro-cholecalciferol derivatives | |
IL139276A0 (en) | Cyclohexenondioxthio chromanoyl derivatives | |
HK1042478A1 (zh) | 2-氧代-2h-喹啉衍生物 | |
GB9816279D0 (en) | Arylthiazolidinedione derivatives | |
SI1051395T1 (sl) | N-hidroksiformamidni derivati | |
IL132162A0 (en) | 2, 3-Epoxypropionamide derivatives | |
IL132162A (en) | 2,3-epoxypropionamide derivatives | |
ZA9811564B (en) | Derivatives of 1,3,4-oxadiazolone |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
HMM4 | Cancellation of final prot. due to non-payment of fee |